Importer of Controlled Substances; Notice of Registration, 34968 [E6-9415]

Download as PDF 34968 Federal Register / Vol. 71, No. 116 / Friday, June 16, 2006 / Notices Cisco Systems, Inc., 170 West Tasman Drive, San Jose, California 95134. Lucent Technologies, Inc., 600 Mountain Avenue, Murray Hill, New Jersey 07974. ´ Alcatel S.A., 54, rue La Boetie, 75008, Paris, France. Alcatel USA, Inc., 3400 W. Plano Parkway, Plano, Texas 75075. PMC–Sierra, Inc., 3975 Freedom Circle, Santa Clara, CA 95054. wwhite on PROD1PC61 with NOTICES (c) The Commission investigative attorney, party to this investigation, is Steven R. Pedersen, Esq., Office of Unfair Import Investigations, U.S. International Trade Commission, 500 E Street, SW., Suite 401, Washington, DC 20436; and (3) For the investigation so instituted, the Honorable Robert L. Barton, Jr. is designated as the presiding administrative law judge. Responses to the amended complaint and the notice of investigation must be submitted by the named respondents in accordance with § 210.13 of the Commission’s Rules of Practice and Procedure, 19 CFR 210.13. Pursuant to 19 CFR 201.16(d) and 210.13(a), such responses will be considered by the Commission if received not later than 20 days after the date of service by the Commission of the amended complaint and the notice of investigation. Extensions of time for submitting responses to the amended complaint and the notice of investigation will not be granted unless good cause therefor is shown. Failure of a respondent to file a timely response to each allegation in the amended complaint and in this notice may be deemed to constitute a waiver of the right to appear and contest the allegations of the amended complaint and this notice, and to authorize the administrative law judge and the Commission, without further notice to the respondent, to find the facts to be as alleged in the amended complaint and this notice and to enter an initial determination and a final determination containing such findings, and may result in the issuance of a limited exclusion order or cease and desist order or both directed against the respondent. Issued: June 9, 2006. By order of the Commission. Marilyn R. Abbott, Secretary to the Commission. [FR Doc. E6–9416 Filed 6–15–06; 8:45 am] BILLING CODE 7020–02–P VerDate Aug<31>2005 18:25 Jun 15, 2006 Jkt 208001 DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Registration By Notice dated January 20, 2006 and published in the Federal Register on January 27, 2006 (71 FR 4612), Cerilliant Corporation, 811 Paloma Drive, Suite A, Round Rock, Texas 78664, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the basic classes of controlled substances listed in Schedule I and II: Drug Schedule Cathinone (1235) .......................... Methcathinone (1237) ................... N-Ethylamphetamine (1475) ......... Gamma hydroxybutyric acid (2010). Ibogaine (7260) ............................. Tetrahydrocannabinols (7370) ...... Mescaline (7381) .......................... 4-Bromo-2,5dimethoxyamphetamine (7391). 4-Bromo-2,5dimethoxyphenethylamine (7392). 4-Methyl-2,5dimethoxyamphetamine (7395). 2,5-Dimethoxyamphetamine (7396). 3,4-Methylenedioxyamphetamine (7400). 3,4-Methylenedioxy-Nethylamphetamine (7404). 3,4Methylenedioxymethamphetamine (7405). 4-Methoxyamphetamine (7411) .... Psilocybin (7437) .......................... Psilocyn (7438) ............................. Etorphine (except HCI) (9056) ..... Heroin (9200) ................................ Pholcodine (9314) ......................... Amphetamine (1100) .................... Methamphetamine (1105) ............. Methylphenidate (1724) ................ Amobarbital (2125) ....................... Pentobarbital (2270) ..................... Cocaine (9041) ............................. Codeine (9050) ............................. Dihydrocodeine (9120) ................. Oxycodone (9143) ........................ Hydromorphone (9150) ................. Benzoylecgonine (9180) ............... Ethylmorphine (9190) ................... Meperidine (9230) ......................... Methadone (9250) ........................ Dextropropoxyphene, bulk (nondosage forms) (9273). Morphine (9300) ........................... Thebaine (9333) ........................... Levo-alphacetylmethadol (9648) .. Oxymorphone (9652) .................... I I I I I I I I I I I Frm 00099 Fmt 4703 Sfmt 4703 Dated: June 7, 2006. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E6–9415 Filed 6–15–06; 8:45 am] BILLING CODE 4410–09–P I I I I I I I I I II II II II II II II II II II II II II II II II II II II The company plans to import small quantities of the listed controlled substances for the manufacture of analytical reference standards. PO 00000 No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and determined that the registration of Cerilliant Corporation to import the basic class of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971, at this time. DEA has investigated Cerilliant Corporation to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic class of controlled substances listed. NEIGHBORHOOD REINVESTMENT CORPORATION Neighborworks America Annual Meeting of the Board of Directors; Sunshine Act TIME & DATE: 3 p.m. Tuesday, June 20, 2006. 1325 G Street, NW., Suite 800, Boardroom, Washington, DC 20005. PLACE: STATUS: Open. FOR FURTHER INFORMATION CONTACT: Jeffrey T. Bryson, General Counsel/ Secretary, (202) 220–2372; jbryson@nw.org. Agenda I. Call to Order II. Approval of the Minutes III. Summary Committee Reports IV. Resolutions of Appreciation V. Chief Executive Officer’s Management Report VI. Adjournment Jeffrey T. Bryson, General Counsel/Secretary. [FR Doc. 06–5503 Filed 6–14–06; 10:53 am] BILLING CODE 7570–02–M E:\FR\FM\16JNN1.SGM 16JNN1

Agencies

[Federal Register Volume 71, Number 116 (Friday, June 16, 2006)]
[Notices]
[Page 34968]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-9415]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration

    By Notice dated January 20, 2006 and published in the Federal 
Register on January 27, 2006 (71 FR 4612), Cerilliant Corporation, 811 
Paloma Drive, Suite A, Round Rock, Texas 78664, made application by 
renewal to the Drug Enforcement Administration (DEA) to be registered 
as an importer of the basic classes of controlled substances listed in 
Schedule I and II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Cathinone (1235)............................  I
Methcathinone (1237)........................   I
N-Ethylamphetamine (1475)...................   I
Gamma hydroxybutyric acid (2010)............  I
Ibogaine (7260).............................  I
Tetrahydrocannabinols (7370)................  I
Mescaline (7381)............................  I
4-Bromo-2,5-dimethoxyamphetamine (7391).....  I
4-Bromo-2,5-dimethoxyphenethylamine (7392)..  I
4-Methyl-2,5-dimethoxyamphetamine (7395)....  I
2,5-Dimethoxyamphetamine (7396).............  I
3,4-Methylenedioxyamphetamine (7400)........  I
3,4-Methylenedioxy-N-ethylamphetamine (7404)  I
3,4-Methylenedioxymethamphetamine (7405)....  I
4-Methoxyamphetamine (7411).................  I
Psilocybin (7437)...........................  I
Psilocyn (7438).............................  I
Etorphine (except HCI) (9056)...............  I
Heroin (9200)...............................  I
Pholcodine (9314)...........................  I
Amphetamine (1100)..........................  II
Methamphetamine (1105)......................  II
Methylphenidate (1724)......................  II
Amobarbital (2125)..........................  II
Pentobarbital (2270)........................  II
Cocaine (9041)..............................  II
Codeine (9050)..............................  II
Dihydrocodeine (9120).......................  II
Oxycodone (9143)............................  II
Hydromorphone (9150)........................  II
Benzoylecgonine (9180)......................   II
Ethylmorphine (9190)........................  II
Meperidine (9230)...........................  II
Methadone (9250)............................  II
Dextropropoxyphene, bulk (non-dosage forms)   II
 (9273).
Morphine (9300).............................  II
Thebaine (9333).............................  II
Levo-alphacetylmethadol (9648)..............  II
Oxymorphone (9652)..........................  II
------------------------------------------------------------------------

    The company plans to import small quantities of the listed 
controlled substances for the manufacture of analytical reference 
standards.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and 952(a) and determined that the 
registration of Cerilliant Corporation to import the basic class of 
controlled substances is consistent with the public interest and with 
United States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971, at this time. DEA has investigated 
Cerilliant Corporation to ensure that the company's registration is 
consistent with the public interest. The investigation has included 
inspection and testing of the company's physical security systems, 
verification of the company's compliance with state and local laws, and 
a review of the company's background and history. Therefore, pursuant 
to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, 
the above named company is granted registration as an importer of the 
basic class of controlled substances listed.

    Dated: June 7, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
 [FR Doc. E6-9415 Filed 6-15-06; 8:45 am]
BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.